Katie Arnold is the Founder and CEO of SPRIG Consulting and a proven executive with 25+ years of strategic marketing and commercial launch experience in the medical products space: medtech, diagnostic, wearables and digital health. Since its inception, SPRIG’s revenue growth has achieved a >30% CAGR, with over 40 company clients achieving exits for values in excess of $35B.
Since 2008, the firm has engaged with over 250 medical companies ranging from venture-backed start-ups to Fortune 500 companies. During this time, Katie has demonstrated an aptitude for delivering flawless launch execution and implementing commercialization strategies in the U.S., EU and AP geographies. Katie recruited an elite team of highly experienced commercial and business development professionals at SPRIG.
Prior to founding SPRIG, Katie’s career included sales (both field clinical and territory manager roles) and marketing management roles with cardiovascular medical device companies Guidant Corporation (acquired by Abbott Laboratories and Boston Scientific) and Kensey Nash Corporation (acquired by Spectranetics Corporation/Royal Philips). At Kensey Nash, Katie was a founding commercial team member and director of marketing. In this role, she built and led the company’s first-ever newly created commercial arm of the Endovascular Division where she built the team and led successful U.S. and O.U.S. product commercial launches. During her tenure at Guidant, Katie was a member of the Vascular Interventions sales team and marketing manager for the U.S. launch of a next generation stent platform.
Katie is currently an adjunct Faculty member at Northwestern University’s Kellogg School of Business, where for nearly a decade she has been a highly rated faculty member teaching medical product commercialization and financing. Katie is an organizing member of the Medtech Women non-profit organization that produces the annual, sold-out conference, Medtech Vision. Most recently, Katie was selected to participate in the Women-In-Bio Chicago 3.8 Initiative, where she completed the Leadership Development Program to promote women leaders on healthcare boards.
Katie received her MBA from the Kellogg Business School, Northwestern University, where she was awarded the Health Industry Management Tuition Scholarship as one of most promising healthcare leaders. She holds a Bachelor’s degree in Environmental Sciences and Chemistry from the University of Vermont where she also serves on the Board of Advisors for the Biomedical Innovation Center.